On April 8, the 2026 (8th) World Health Expo opened at the Optics Valley Convention & Exhibition Center. During a media interview at the event, Liu Baolin, founder and honorary chairman of Jointown Pharmaceutical Group, revealed that “Jointown has added another listed company. We have now completed the acquisition of Aoyuan Beauty Valley, which has officially been renamed Jointown Beauty Valley.”
Founded in June 1993, Aoyuan Beauty Valley was listed on the Shenzhen Stock Exchange in October 1996. Its core businesses include medical aesthetic services and bio-based fibers. In April 2025, Jointown announced that it would invest RMB 673 million to participate in the restructuring of Aoyuan Beauty Valley, with the aim of bringing the medical aesthetics company under its umbrella. In September of the same year, the restructuring investment plan was adjusted, increasing the number of shares to be acquired by Jointown from 360 million shares to 436 million shares, with the corresponding investment amount revised to RMB 706 million.
Last December, Aoyuan Beauty Valley received a Civil Ruling from the Intermediate People’s Court of Xiangyang City, Hubei Province, approving the “Restructuring Plan of Aoyuan Beauty Valley Technology Co., Ltd.” and terminating the company’s restructuring proceedings, marking its formal entry into the restructuring implementation phase. In February this year, the company announced that it had officially changed its name to Jointown Beauty Valley Technology Co., Ltd., while its registered capital increased from RMB 763 million to RMB 1.788 billion.
As of now, Hubei Jointown Industrial Park Operation Management Co., Ltd., a subsidiary of Jointown, holds a 24.39% stake in Jointown Beauty Valley, making it the controlling shareholder. According to previous earnings guidance, Jointown Beauty Valley is expected to generate revenue of RMB 850 million to RMB 1.05 billion in 2025. In 2024, its medical aesthetics business generated RMB 624 million in revenue, accounting for 57% of total revenue.
In addition, during the first three quarters of 2025, Jointown reported revenue of RMB 119.3 billion and net profit attributable to shareholders of RMB 1.975 billion, representing year-on-year increases of 5.2% and 16.46%, respectively.
